- $1.37bn
- $1.47bn
- $788.94m
- 54
- 74
- 45
- 58
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.4 | ||
Price to Tang. Book | 2.63 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.73 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -4.45% | ||
Return on Equity | -7.25% | ||
Operating Margin | -22.15% |
Financial Summary
Year End 31st May | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 210.48 | 513.09 | 628.37 | 627.12 | 788.94 | 914.54 | 981.35 | 36.42% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.
Directors
- Irwin Simon CHM (63)
- Renah Persofsky NVC (63)
- Carl Merton CFO
- Denise Faltischek OTH (47)
- James Meiers OTH (63)
- Brendan Kennedy DRC (49)
- Jodi Butts IND (49)
- David Clanachan IND (59)
- John Herhalt IND (64)
- David Hopkinson IND (50)
- Thomas Looney IND (58)
- Walter Robb IND (67)
- Last Annual
- May 31st, 2024
- Last Interim
- May 31st, 2024
- Incorporated
- January 24th, 2018
- Public Since
- July 19th, 2018
- No. of Shareholders
- 900
- No. of Employees
- 2,650
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 842,961,757
- Address
- 655 Madison Avenue, 19Th Floor, NEW YORK, 10065
- Web
- https://www.tilray.com/
- Phone
- +1 4169342141
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for TLRY
Tilray Brands Inc Annual Shareholders Meeting
Q2 2025 Tilray Brands Inc Earnings Release
Similar to TLRY
Amgen
NASDAQ Global Select Market
Amneal Pharmaceuticals
NASDAQ Global Select Market
Amphastar Pharmaceuticals
NASDAQ Global Select Market
Amylyx Pharmaceuticals
NASDAQ Global Select Market
Apellis Pharmaceuticals
NASDAQ Global Select Market
FAQ
As of Today at 17:42 UTC, shares in Tilray Brands are trading at $1.62. This share price information is delayed by 15 minutes.
Shares in Tilray Brands last closed at $1.62 and the price had moved by -45.27% over the past 365 days. In terms of relative price strength the Tilray Brands share price has underperformed the S&P500 Index by -54.89% over the past year.
The overall consensus recommendation for Tilray Brands is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreTilray Brands does not currently pay a dividend.
Tilray Brands does not currently pay a dividend.
Tilray Brands does not currently pay a dividend.
To buy shares in Tilray Brands you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.62, shares in Tilray Brands had a market capitalisation of $1.37bn.
Here are the trading details for Tilray Brands:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: TLRY
Based on an overall assessment of its quality, value and momentum Tilray Brands is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Tilray Brands is $2.39. That is 47.53% above the last closing price of $1.62.
Analysts covering Tilray Brands currently have a consensus Earnings Per Share (EPS) forecast of -$0.09 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tilray Brands. Over the past six months, its share price has underperformed the S&P500 Index by -9.82%.
As of the last closing price of $1.62, shares in Tilray Brands were trading -14.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tilray Brands PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.62.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tilray Brands' management team is headed by:
- Irwin Simon - CHM
- Renah Persofsky - NVC
- Carl Merton - CFO
- Denise Faltischek - OTH
- James Meiers - OTH
- Brendan Kennedy - DRC
- Jodi Butts - IND
- David Clanachan - IND
- John Herhalt - IND
- David Hopkinson - IND
- Thomas Looney - IND
- Walter Robb - IND